HCV NS3 protease inhibitors

Details for Australian Patent Application No. 2007309488 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors McCauley, John A.; Rudd, Michael T.; Vacca, Joseph P.; Romano, Joseph J.; Liverton, Nigel J.

Agent Spruson & Ferguson

Pub. Number AU-B-2007309488

PCT Pub. Number WO2008/051514

Priority 60/853,964 24.10.06 US

Filing date 22 October 2007

Wipo publication date 2 May 2008

Acceptance publication date 11 October 2012

International Classifications

A61K 31/56 - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 38/00 Medicinal preparations containing peptides

Event Publications

21 May 2009 PCT application entered the National Phase

  PCT publication WO2008/051514 Priority application(s): WO2008/051514

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp. Amendments

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

11 October 2012 Application Accepted

  Published as AU-B-2007309488

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007309503-Cleaning apparatus with disposable elements and methods of cleaning

2007309479-Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage